Medifast (MED) Free Cash Flow (2010 - 2026)

Medifast has reported Free Cash Flow for 17 years, with the latest figure at -$836000.0 in Q1 2026.

• For the quarter ending Q1 2026, Free Cash Flow fell 144.37% year-over-year to -$836000.0; the trailing twelve-month figure through Mar 2026 stood at -$1.5 million (down 110.92% YoY), and the FY2025 full-year result was $1.2 million, down 92.66% from the prior year.
• Free Cash Flow for Q1 2026 stood at -$836000.0, up from -$6.6 million in the prior quarter.
• The five-year high for Free Cash Flow was $61.9 million in Q1 2023, with the low at -$7.2 million in Q4 2024.
• Historically, Free Cash Flow has averaged $19.8 million across 5 years, with a median of $10.8 million in 2025.
• Annual changes were most pronounced in 2022 — Free Cash Flow soared 891.09% — and 2024, when it slumped 175.52%.
• Medifast's Free Cash Flow stood at $42.7 million in 2022, then tumbled by 77.56% to $9.6 million in 2023, then tumbled by 175.52% to -$7.2 million in 2024, then advanced by 8.34% to -$6.6 million in 2025, then surged by 87.39% to -$836000.0 in 2026.
• The last three Free Cash Flow figures came in at -$836000.0 (Q1 2026), -$6.6 million (Q4 2025), and $10.8 million (Q3 2025), per Business Quant data.